Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Single Cell Genomics & Transcriptomics Asia Congress 2013

13 Jun 2013 - 14 Jun 2013 - Singapore

Bookmark and Share

Oxford Global is proud to present the Single Cell Genomics & Transcriptomics Congress taking place on 13th & 14th June 2013 in Singapore. The congress is dedicated to the most pressing challenges and critical opportunities in the field of Single Cell Genomics & Transcriptomics, creating a focused platform for scientific debate and executive-level networking.

The value of the genomics market is expected to increase by 11% in the next two years. As the only conference to bring together all the experts in the global field of single cell genomics and transcriptomics, this exciting and important meeting is a must for everyone working in the field of single cells.

Over the two days, the event will attract over 175 senior-level decision markers from Europe, US and Asia with a comprehensive conference program featuring two separate streams, key note addresses, case study presentations and interactive panel discussions given by over 30 expert speakers from leading academic and research institutes.

Day One, our panel of genomics and transcriptomics experts will look at advances in single cell analysis and breakthrough technologies including amplification and isolation methods. Discover innovative solutions for integrating proteomics and metabolomics information.

Day Two, our internationally renowned speakers will explore the application of single cell genomics in a range of therapeutic areas and corresponding implications in clinical and diagnostic development. Do not miss out on the latest developments in single cell sequencing and transcriptome analysis of single cells, as well as case studies on the latest novel analysis platforms.

The Single Cell Genomics & Transcriptomics Congress is part of the highly successful Oxford Global Next Generation Sequencing Series. For more information on other events in the series, please see below:

  • NGS Data Analysis & Management Congress, 17 – 18 June 2013, London

Further information
Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos